尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Deshpande Milind. Insider active across 1 company, notably Spero Therapeutics, Inc.. Cumulatively, 5 filings have been recorded. History available since 15 September 2022. The latest transaction was disclosed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Deshpande Milind is a declarant linked to Spero Therapeutics, Inc., where he is a Director. The record shows 5 filings in total, and across the recent filings available from 2022-09-19 to 2026-06-25, the buy and sell amounts are 0 and 0 EUR, with the transaction nature listed as Attribution.